Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by kristian7on Aug 30, 2017 9:44pm
293 Views
Post# 26640211

RE:RE:RE:RE:RE:RE:My price is at least 1.70 CAD!!!

RE:RE:RE:RE:RE:RE:My price is at least 1.70 CAD!!!
StockReddy wrote: Plasminogen is a naturally occurring human protein produced by the liver, hence FDA will approve for sure (>99.99%). 

REDDY


I agree ! 100% will be approved. The inspection of our GMP Laval will be done very soon and then it's just a matter of a few weeks before we get the GO AHEAD !!! Short Squeeze !!!!
Bullboard Posts